Ekso Bionics Holdings, Inc.

5.25+0.44 (+9.06%)
Oct 29, 4:00:02 PM EDT · NasdaqCM · EKSO · USD

Upcoming Earnings

Report date
-
EPS
-0.29 (-0.52 ~ -0.07)
Revenue
4.75M (4.30M ~ 5.20M)

Key Stats

Market Cap
13.71M
P/E (TTM)
-
Basic EPS (TTM)
-6.49
Dividend Yield
0%

Recent Filings

About

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

CEO
Mr. Scott G. Davis
IPO
1/17/2014
Employees
61
Sector
Healthcare
Industry
Medical Instruments & Supplies